CD8A and neoplasm: Although combinations of specific peptides have successfully induced T cell responses in humans and protected mice from viral challenges, vaccination with a CTL epitope derived from the human adenovirus type 5 E1A region (Ad5E1A234-243) actually enhanced tumor growth rather than inhibiting it, due to CD8+ T cell tolerance [105].